Inhibitors of lipoprotein-associated phospholipase A2

被引：0
|
作者：
Barrett, D
Barlocco, D
机构：
[1] Fujisawa Pharmaceut Co Ltd, Yodogawa Ku, Osaka 5328514, Japan
[2] Univ Milan, I-20131 Milan, Italy
来源：
DRUG DISCOVERY TODAY | 2001年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [41] Lipoprotein-associated phospholipase A2: Risk marker or target of therapy?
    Ballantyne C.M.
    Current Cardiovascular Risk Reports, 2007, 1 (1) : 66 - 71
  • [42] Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
    Muriel J Caslake
    Chris J Packard
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 529 - 535
  • [43] Lipoprotein-associated phospholipase a2 in a population of patients with metabolic syndrome
    Rosenbaum, D.
    Hansel, B.
    Bittar, R.
    Charniot, J. C.
    Girerd, X.
    Bruckert, E.
    Rousselot, D. Bonnefont
    Giral, P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 695 - 696
  • [44] The role of lipoprotein-associated phospholipase A2 in the metabolic syndrome and diabetes
    Noto, Hiroshi
    Chitkara, Pranav
    Raskin, Philip
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (06) : 343 - 348
  • [45] Lipoprotein-associated phospholipase A2: A paradigm for allosteric regulation by membranes
    Mouchlis, Varnavas D.
    Hayashi, Daiki
    Vasquez, Alexis M.
    Cao, Jian
    McCammon, J. Andrew
    Dennis, Edward A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (02)
  • [46] Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke
    Caslake, MJ
    Packard, CJ
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (10): : 529 - 535
  • [47] Translational Studies of Lipoprotein-Associated Phospholipase A2 in Inflammation and Atherosclerosis
    Ferguson, Jane F.
    Hinkle, Christine C.
    Mehta, Nehal N.
    Bagheri, Roshanak
    DerOhannessian, Stephanie L.
    Shah, Rhia
    Mucksavage, Megan I.
    Bradfield, Jonathan P.
    Hakonarson, Hakon
    Wang, Xuexia
    Master, Stephen R.
    Rader, Daniel J.
    Li, Mingyao
    Reilly, Muredach P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (08) : 764 - 772
  • [48] Lipoprotein-associated phospholipase A2 and venous thromboembolism: A prospective study
    Folsom, Aaron R.
    Lutsey, Pamela L.
    Roetker, Nicholas S.
    Ballantyne, Christie M.
    Hoogeveen, Ron C.
    Rosamond, Wayne D.
    Cushman, Mary
    THROMBOSIS RESEARCH, 2013, 132 (01) : 44 - 46
  • [49] Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity
    Beulens, Joline W. J.
    van den Berg, Robin
    Kok, Frans J.
    Helander, Anders
    Vermunt, Susan H. F.
    Hendriks, Henk F. J.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (08) : 539 - 544
  • [50] Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications
    Maiolino, Giuseppe
    Bisogni, Valeria
    Rossitto, Giacomo
    Rossi, Gian Paolo
    WORLD JOURNAL OF CARDIOLOGY, 2015, 7 (10): : 609 - 620
12345